NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/02/2026
Voltar para busca
Dado oficial do USPTO
ZIPHIUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Snapshot rápido
ST13
US500000079366886Classe
5, 9, 10, 35, 42, 44
Pedido
79366886
Registro
7490637
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
03/04/2026
Tipo de marca
Mista
Classes Nice
5, 9, 10, 35, 42, 44
Data de depósito
03/03/2023
Data de registro
03/09/2024
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/09/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
98
Localização do titular
BE
Examinador
TURNER, JASON FITZGERALD
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of a stylized dolphin in shades of blue to the left of the blue stylized word "ZIPHIUS".
Titulares e representantes
Titulares
ZIPHIUS
ZIPHIUS VACCINES NV
Representantes
Andrea S. Fuelleman Neal, Gerber & Eisenberg LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and medicinal preparations and substances for the treatment of genetic disordersinfectious diseasesparasitic diseasesoncology in the field of cystic Fibrosischlamydia trachomatiseppstein barrherpes zosterherpes simplexcoronavirusesmalarialeishmaniasistrypanosomiasis; chikungunyadenguelymphatic filariasisrift valley feveryellow feverzikamalariaJapanese encephalitisWest Nile feverschistosomiasis (bilharziasis)Onchocerciasis (river blindness)plaguestungiasistyphuslouse-borne relapsing feverLeishmaniasisSandfly fever (Phlebotomus fever)Crimean Congo haemorrhagic feverLyme diseaseRelapsing fever (borreliosis)rickettsial diseasesTick-borne encephalitistularaemiachagas disease (American trypanosomiasis)sleeping sickness (African trypanosomiasis)all of the foregoing based on self-amplifying RNA and Lipid based delivery vehicles; vaccines
Classe 9
Downloadable mobile applications and downloadable computer software to enable healthcare professionals and patients to access information on pharmaceuticalmedical and vaccine products and services; Downloadable e-commerce software to enable users to perform electronic business transactions via a global computer network; Downloadable computer software to enable professionals to optimize workflowcapture and organize informationplace orders and track expenses
Classe 10
Surgical apparatus and instruments for medical use; blood pressure and diabetic diagnostic medical devices
Classe 35
Provision of information and advisory services relating to electronic commerce; provision of customer information on pharmaceutical and medical products through an on-line computer network for advertising purposes
Classe 42
Scientific research for medical purposes
Classe 44
Medical services and healthcare services namelyoffered through a network of healthcare providers on a contract basis; provision of medical information; provision of medical information to patients and healthcare professionals concerning pharmaceutical productsvaccinesmedical diseases and disorders and related treatments via the Internet; gene therapy and stem cell therapy services; medical and psychological counselling services; medical and pharmaceutical consultation; medical diagnostic testingmonitoring and reporting services; genetic testing for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/11/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/03/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/02/2025
FIMP
FINAL DISPOSITION PROCESSED
18/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/12/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
28/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/06/2024
PUBO
PUBLISHED FOR OPPOSITION
18/06/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/06/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/05/2024
RFNT
REFUSAL PROCESSED BY IB
02/01/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/12/2023
RFRR
REFUSAL PROCESSED BY MPU
11/12/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/12/2023
CNRT
NON-FINAL ACTION WRITTEN
07/12/2023
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
04/12/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/12/2023
CNRT
NON-FINAL ACTION WRITTEN
02/12/2023
DOCK
ASSIGNED TO EXAMINER
02/12/2023
MAFR
APPLICATION FILING RECEIPT MAILED
18/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/04/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/04/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZIPHIUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.